{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:48:03Z","timestamp":1787032083945,"version":"build-2736575974"},"reference-count":40,"publisher":"Japan Atherosclerosis Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2025,7,1]]},"DOI":"10.5551\/jat.65162","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T17:14:09Z","timestamp":1735146849000},"page":"853-862","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic Ability of Risk Models in the Field of Ischemic Stroke for Predicting Atherosclerotic Outcomes in Patients with Acute Myocardial Infarction"],"prefix":"10.5551","volume":"32","author":[{"given":"Hiroki","family":"Goto","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Yaginuma","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Asada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chiba Emergency and Psychiatric Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kitahara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Chiba University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Faxon DP, Fuster V, Libby P, Beckman JA, Hiatt WR, Thompson RW, Topper JN, Annex BH, Rundback JH, Fabunmi RP, Robertson RM, Loscalzo J; American Heart Association. Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. Circulation, 2004; 109: 2617-2625","DOI":"10.1161\/01.CIR.0000128520.37674.EF"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Pasternak RC, Criqui MH, Benjamin EJ, Fowkes FG, Isselbacher EM, McCullough PA, Wolf PA, Zheng ZJ. Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology. Circulation, 2004; 109: 2605-2612","DOI":"10.1161\/01.CIR.0000128518.26834.93"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Hurskainen M, Tynkkynen J, Eskola M, Hernesniemi J. Incidence of stroke and mortality due to stroke after acute coronary syndrome. J Stroke Cerebrovasc Dis, 2022; 31: 106842","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106842"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Boulanger M, Li L, Lyons S, Lovett NG, Kubiak MM, Silver L, Touz\u00e9 E, Rothwell PM. Essen Risk Score in Prediction of Myocardial Infarction After Transient Ischemic Attack or Ischemic Stroke Without Prior Coronary Artery Disease. Stroke, 2019; 50: 3393-3399","DOI":"10.1161\/STROKEAHA.119.025831"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kamouchi M, Kumagai N, Okada Y, Origasa H, Yamaguchi T, Kitazono T. Risk score for predicting recurrence in patients with ischemic stroke: the Fukuoka stroke risk score for Japanese. Cerebrovasc Dis, 2012; 34: 351-357","DOI":"10.1159\/000343503"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Weimar C, Diener HC, Alberts MJ, Steg PG, Bhatt DL, Wilson PW, Mas JL, R\u00f6ther J; REduction of Atherothrombosis for Continued Health Registry Investigators. The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry. Stroke, 2009; 40: 350-354","DOI":"10.1161\/STROKEAHA.108.521419"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kernan WN, Viscoli CM, Brass LM, Makuch RW, Sarrel PM, Roberts RS, Gent M, Rothwell P, Sacco RL, Liu RC, Boden-Albala B, Horwitz RI. The stroke prognosis instrument II (SPI-II): A clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke. Stroke, 2000; 31: 456-462","DOI":"10.1161\/01.STR.31.2.456"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Matsumoto T, Saito Y, Yamashita D, Sato T, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Impact of Active and Historical Cancer on Short- and Long-Term Outcomes in Patients With Acute Myocardial Infarction. Am J Cardiol, 2021; 159: 59-64","DOI":"10.1016\/j.amjcard.2021.08.021"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Yamashita D, Saito Y, Sato T, Matsumoto T, Saito K, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Impact of PARIS and CREDO-Kyoto Thrombotic and Bleeding Risk Scores on Clinical Outcomes in Patients With Acute Myocardial Infarction. Circ J, 2022; 86: 622-629","DOI":"10.1253\/circj.CJ-21-0556"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Matsumoto T, Saito Y, Sato T, Yamashita D, Suzuki S, Saito K, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Validation of the Domestic High Bleeding Risk Criteria for Japanese Patients with Acute Myocardial Infarction. J Atheroscler Thromb, 2023; 30: 299-309","DOI":"10.5551\/jat.63576"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Suzuki S, Saito Y, Yamashita D, Matsumoto T, Sato T, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Clinical Characteristics and Prognosis of Patients With No Standard Modifiable Risk Factors in Acute Myocardial Infarction. Heart Lung Circ, 2022; 31: 1228-1233","DOI":"10.1016\/j.hlc.2022.06.666"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Sato T, Saito Y, Suzuki S, Matsumoto T, Yamashita D, Saito K, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Prognostic Factors of In-Hospital Mortality in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock. Life (Basel), 2022; 12: 1672","DOI":"10.3390\/life12101672"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Asada K, Saito Y, Sato T, Matsumoto T, Yamashita D, Suzuki S, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Prognostic Value of Natriuretic Peptide Levels and In-Hospital Heart Failure Events in Patients With Acute Myocardial Infarction. Circ J, 2023; 87: 640-647","DOI":"10.1253\/circj.CJ-22-0577"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Goto H, Saito Y, Matsumoto T, Sato T, Yamashita D, Suzuki S, Wakabayashi S, Kitahara H, Sano K, Kobayashi Y. Differential Impact of Clinical Factors for Predicting High Platelet Reactivity on Clinical Outcomes in Acute Myocardial Infarction Patients Treated With Clopidogrel and Prasugrel. J Atheroscler Thromb, 2023; 30: 1791-1802","DOI":"10.5551\/jat.64217"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Nomura T, Wada N, Ota I, Tasaka S, Ono K, Sakaue Y, Shoji K, Keira N, Tatsumi T. Early experience with coronary debulking devices in a newcomer facility after introducing revised facility criteria in Japan. Cardiovasc Interv Ther, 2023; 38: 104-112","DOI":"10.1007\/s12928-022-00885-9"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Saito Y, Kobayashi Y, Fujii K, Sonoda S, Tsujita K, Hibi K, Morino Y, Okura H, Ikari Y, Kozuma K, Honye J. CVIT 2023 clinical expert consensus document on intravascular ultrasound. Cardiovasc Interv Ther, 2024; 39: 1-14","DOI":"10.1007\/s12928-023-00957-4"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Sonoda S, Hibi K, Okura H, Fujii K, Node K, Kobayashi Y, Honye J. Current clinical use of intravascular ultrasound imaging to guide percutaneous coronary interventions (update). Cardiovasc Interv Ther, 2023; 38: 1-7","DOI":"10.1007\/s12928-022-00892-w"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Saito Y, Kobayashi Y. Contemporary coronary drug-eluting and coated stents: an updated mini-review (2023). Cardiovasc Interv Ther, 2024; 39: 15-17","DOI":"10.1007\/s12928-023-00954-7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Saito Y, Tateishi K, Kanda M, Shiko Y, Kawasaki Y, Kobayashi Y, Inoue T. Volume-outcome relationships for extracorporeal membrane oxygenation in acute myocardial infarction. Cardiovasc Interv Ther, 2024; 39: 156-163","DOI":"10.1007\/s12928-023-00976-1"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf of the Joint European Society of Cardiology (ESC)\/American College of Cardiology (ACC)\/American Heart Association (AHA)\/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol, 2018; 72: 2231-2264","DOI":"10.1016\/j.jacc.2018.08.1038"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Weimar C, Benemann J, Michalski D, M\u00fcller M, Luckner K, Katsarava Z, Weber R, Diener HC; German Stroke Study Collaboration. Prediction of recurrent stroke and vascular death in patients with transient ischemic attack or nondisabling stroke: a prospective comparison of validated prognostic scores. Stroke, 2010; 41: 487-493","DOI":"10.1161\/STROKEAHA.109.562157"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Meng X, Wang Y, Zhao X, Wang C, Li H, Liu L, Zhou Y, Xu J, Wang Y. Validation of the Essen Stroke Risk Score and the Stroke Prognosis Instrument II in Chinese patients. Stroke, 2011; 42: 3619-3620","DOI":"10.1161\/STROKEAHA.111.624148"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KA; Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med, 2003; 163: 2345-2353","DOI":"10.1001\/archinte.163.19.2345"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant, 2013; 48: 452-458","DOI":"10.1038\/bmt.2012.244"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Mu\u00f1oz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B. 2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 2019; 140: e596-e646","DOI":"10.1161\/CIR.0000000000000678"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, Goto S, Liau CS, Richard AJ, R\u00f6ther J, Wilson PW; REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA, 2006; 295: 180-189","DOI":"10.1001\/jama.295.2.180"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Cacoub PP, Zeymer U, Limbourg T, Baumgartner I, Poldermans D, R\u00f6ther J, Bhatt DL, Steg PG; REACH Registry Investigators. Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe. Heart, 2011; 97: 660-667","DOI":"10.1136\/hrt.2010.213710"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Chew DP, Hyun K, Morton E, Horsfall M, Hillis GS, Chow CK, Quinn S, D\u2019Souza M, Yan AT, Gale CP, Goodman SG, Fox K, Brieger D. Objective Risk Assessment vs Standard Care for Acute Coronary Syndromes: A Randomized Clinical Trial. JAMA Cardiol, 2021; 6: 304-313","DOI":"10.1001\/jamacardio.2020.6314"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Khan SS, Matsushita K, Sang Y, Ballew SH, Grams ME, Surapaneni A, Blaha MJ, Carson AP, Chang AR, Ciemins E, Go AS, Gutierrez OM, Hwang SJ, Jassal SK, Kovesdy CP, Lloyd-Jones DM, Shlipak MG, Palaniappan LP, Sperling L, Virani SS, Tuttle K, Neeland IJ, Chow SL, Rangaswami J, Pencina MJ, Ndumele CE, Coresh J. Chronic Kidney Disease Prognosis Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group. Development and Validation of the American Heart Association\u2019s PREVENT Equations. Circulation, 2024; 149: 430-449","DOI":"10.1161\/CIRCULATIONAHA.123.067626"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Samarasekera EJ, Clark CE, Kaur S, Patel RS, Mills J. Cardiovascular disease risk assessment and reduction: summary of updated NICE guidance. BMJ, 2023; 381: 1028","DOI":"10.1136\/bmj.p1028"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ, 2017; 357: j2099","DOI":"10.1136\/bmj.j2099"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J, 2021; 42: 2439-2454","DOI":"10.1093\/eurheartj\/ehab309"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Baber U, Mehran R, Giustino G, Cohen DJ, Henry TD, Sartori S, Ariti C, Litherland C, Dangas G, Gibson CM, Krucoff MW, Moliterno DJ, Kirtane AJ, Stone GW, Colombo A, Chieffo A, Kini AS, Witzenbichler B, Weisz G, Steg PG, Pocock S. Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. J Am Coll Cardiol, 2016; 67: 2224-2234","DOI":"10.1016\/j.jacc.2016.02.064"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Natsuaki M, Morimoto T, Yamaji K, Watanabe H, Yoshikawa Y, Shiomi H, Nakagawa Y, Furukawa Y, Kadota K, Ando K, Akasaka T, Hanaoka KI, Kozuma K, Tanabe K, Morino Y, Muramatsu T, Kimura T; CREDO\u2010Kyoto PCI\/CABG Registry Cohort 2, RESET, and NEXT trial investigators. Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO-Kyoto Thrombotic and Bleeding Risk Scores. J Am Heart Assoc, 2018; 7: e008708","DOI":"10.1161\/JAHA.118.008708"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Pros N, Cambou JP, Aboyans V, Malloizel Delaunay J, Constans J, Lacroix P, Saint L\u00e8bes B, Curaudeau E, Bura A. A hospital discharge risk score for 1-year all-cause mortality or non-fatal cardiovascular events in patients with lower-extremity peripheral artery disease, with and without revascularisation. Eur J Vasc Endovasc Surg, 2013; 45: 488-496","DOI":"10.1016\/j.ejvs.2013.01.034"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Chaudhary D, Abedi V, Li J, Schirmer CM, Griessenauer CJ, Zand R. Clinical Risk Score for Predicting Recurrence Following a Cerebral Ischemic Event. Front Neurol, 2019; 10: 1106","DOI":"10.3389\/fneur.2019.01106"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Scheldeman L, Sinnaeve P, Albers GW, Lemmens R, Van de Werf F. Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review. Eur Heart J, 2024; 45: 2735-2747","DOI":"10.1093\/eurheartj\/ehae371"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Figtree GA, Vernon ST, Hadziosmanovic N, Sundstr\u00f6m J, Alfredsson J, Arnott C, Delatour V, Le\u00f3sd\u00f3ttir M, Hagstr\u00f6m E. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data. Lancet, 2021; 397: 1085-1094","DOI":"10.1016\/S0140-6736(21)00272-5"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Levine GN, Jeong YH, Goto S, Anderson JL, Huo Y, Mega JL, Taubert K, Smith SC Jr. Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI. Nat Rev Cardiol, 2014; 11: 597-606","DOI":"10.1038\/nrcardio.2014.104"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Mensah GA, Fuster V, Murray CJL, Roth GA; Global Burden of Cardiovascular Diseases and Risks Collaborators. Global Burden of Cardiovascular Diseases and Risks, 1990-2022. J Am Coll Cardiol, 2023; 82: 2350-2473","DOI":"10.1016\/j.jacc.2023.11.007"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/7\/32_65162\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T23:45:39Z","timestamp":1751672739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/7\/32_65162\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65162","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"article-number":"65162"}}